Pesquisas alternativas:
"so opens" » "o opens" (Expandir a Pesquisa), "who opens" (Expandir a Pesquisa), "_ opens" (Expandir a Pesquisa), "do opens" (Expandir a Pesquisa), "ao opens" (Expandir a Pesquisa), "caso opens" (Expandir a Pesquisa), "sdo opens" (Expandir a Pesquisa), "sao opens" (Expandir a Pesquisa), "so openss" (Expandir a Pesquisa)
"eo opens" » "e1 opens" (Expandir a Pesquisa), "o opens" (Expandir a Pesquisa), "dea opens" (Expandir a Pesquisa), "edo opens" (Expandir a Pesquisa), "eao opens" (Expandir a Pesquisa), "eo openss" (Expandir a Pesquisa)
"so open" » "do open" (Expandir a Pesquisa), "ao open" (Expandir a Pesquisa), "caso open" (Expandir a Pesquisa), "sdo open" (Expandir a Pesquisa), "sao open" (Expandir a Pesquisa), "so opens" (Expandir a Pesquisa)
"o open" » "do open" (Expandir a Pesquisa), "ao open" (Expandir a Pesquisa), "o opens" (Expandir a Pesquisa)
"esmo open" » "esmdo open" (Expandir a Pesquisa), "esmao open" (Expandir a Pesquisa), "esmo opens" (Expandir a Pesquisa), "esto open" (Expandir a Pesquisa), "eso open" (Expandir a Pesquisa), "ecmo open" (Expandir a Pesquisa)
A mostrar 21 - 40 resultados de 431 para a pesquisa '(((((("eo opens") OR ("o open"))) OR ("esmo open"))) OR ((("so open") OR ("so opens"))))*', tempo de pesquisa: 1.25seg Refinar resultados
Towards shedding some light on regorafenib treatment in refractory metastatic colorectal cancer
Thank you to our reviewers 2016

Concerning the article by Louveau et al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor”
Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…

Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup
Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor

New molecular and immunotherapeutic approaches in biliary cancer
CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion

Upper tract urothelial carcinoma: a different disease entity in terms of management
Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)

Educational video: the role of PD-L1 in the local tumour microenvironment
Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

Multiple primary tumours: challenges and approaches, a review
Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab

New treatment options for metastatic renal cell carcinoma
The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches

Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?
Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?

Highlights for ESMO 40: celebration review for lifetime achievement awards
Drug development: successes, problems and pitfalls—the industry perspective

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa